Washington, D.C. - June 11, 2026

Trump Administration Ends Gender-Related Healthcare Coverage in Federal Insurance Plans, Prompting Employee Complaint

The Trump administration’s policy ending coverage for gender-related medical interventions in federal employee health insurance plans took effect Thursday, leading to a formal complaint filed with the Equal Employment Opportunity Commission by the Human Rights Campaign on behalf of affected federal workers.

The Office of Personnel Management announced in August that federal health plans for employees and U.S. Postal Service workers would no longer cover “chemical and surgical modification of an individual’s sex traits through medical interventions.”

The complaint argues that the change constitutes sex-based discrimination and calls for the policy to be revoked. It includes statements from four current federal employees at the State Department, Health and Human Services, and the Postal Service who say they or their dependents would be directly affected.

One Postal Service employee cited in the complaint has a daughter for whom doctors have recommended puberty blockers and possibly hormone replacement therapy due to gender dysphoria. These treatments would no longer be covered under the new policy.

The complaint is filed on behalf of the workers and a broader class of similarly situated federal employees.

Earlier this year, the House of Representatives passed legislation by a 216-211 vote that would criminalize gender transition treatments for minors, including surgery and hormone administration, and impose penalties of up to ten years in federal prison on providers.

The bill, advanced by Rep. Marjorie Taylor Greene (R-Ga.), was brought to the floor in exchange for her support of the defense policy measure. Greene described the legislation as fulfilling one of President Trump’s key campaign pledges.

“Most Americans agree that kids just need to grow up before they do anything radical, like a mastectomy on a 15-year-old girl,” Greene said on the House floor.

The measure is unlikely to advance in the Senate. Trump administration officials, including Health and Human Services Secretary Robert F. Kennedy Jr., have characterized gender-affirming care for minors as malpractice.